No profile data available.
Cytek Biosciences, Inc. (CTKB) is a healthcare company in the biological analysis equipment industry, based in Fremont, United States, with about 682 full-time employees.
It reported revenue of $200.45 million for fiscal year 2024, up 3.9% from fiscal year 2023, and net income of -$6.02 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $52.29 million, up 1.5% from a year before. United States was its largest region in fiscal year 2025, with 47% of revenue. Its market capitalization was $705.81 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications.
Cytek Biosciences reported $200.45 million in revenue for fiscal year 2024, up 3.9% from $193.02 million in fiscal year 2023. In Q3 2025 revenue was $52.29 million.
United States: 47% of revenue by region in fiscal year 2025, followed by EMEA (28%).
$705.81 million as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include 10x Genomics, Inc. (TXG), BioLife Solutions, Inc. (BLFS), Pacific Biosciences of California, Inc. (PACB), Standard BioTools Inc. (LAB).